Multiorgan dysfunctions in diabetic patients: The role of functional imaging

Minerva Endocrinologica

Volumn 34, Issue 3, 2009, Pages 223-236

  Shah, S ^a   Win, Z ^a,b   Al Nahhas, A ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b HILLINGDON HOSPITAL   (United Kingdom)

Author keywords

Cardiovascular diaseases; Diabetes mellitus, complications; Diabetic foot; Myocardial perfusion imaging; Radionuclide imaging; Tomography, emission computed

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; PENTETATE TECHNETIUM TC 99M; SUCCIMER TC 99M;

BONE SCINTISCANNING; CLINICAL EVALUATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIABETIC FOOT; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FUNCTIONAL ASSESSMENT; HEART SCINTISCANNING; HUMAN; MULTIPLE ORGAN FAILURE; OSTEOARTHROPATHY; OSTEOMYELITIS; POSITRON EMISSION TOMOGRAPHY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; BONE; CARDIOVASCULAR DISEASE; LEUKOCYTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; SCINTISCANNING;

BONE AND BONES; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; DIABETIC FOOT; HUMANS; LEUKOCYTES; MAGNETIC RESONANCE IMAGING; MULTIPLE ORGAN FAILURE; POSITRON-EMISSION TOMOGRAPHY;

EID: 77949903359     PISSN: 03911977     EISSN: 18271634     Source Type: Journal    
DOI: None     Document Type: Review

References (66)

1. International Diabetes Federation. Diabetes Atlas, 3rd edition. 2006.
2. Larkin JG, Frier BM, Ireland JT. Diabetes mellitus and infection. Postgrad Med J 1985;61:233-7.
3. Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV et al. Diabetes and cardiovascular disease: a Statement for healthcare professionals from the American Heart Association. Circulation 1999;100:1134-46. (Pubitemid 29416243)
4. Hammoud T, Tanguay J-F, Bourassa MG. Management of coronary artery disease: therapeutic options in patients with diabetes. J Am Coll Cardiol 2000;36:355-65. (Pubitemid 30627410)
5. Goraya TY, Leibson CL, Palumbo PJ, Weston SA, Killian JM, Pfeifer EA et al. Coronary atherosclerosis in diabetes mellitus: a population-based autopsy study. J Am Coll Cardiol 2002;40:946-53.
6. Clarkson P, Celermajer DS, Donald AE. Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels. J Am Coll Cardiol 1996;28:573-9. (Pubitemid 126745496)
7. American Diabetes Association. Consensus Development Conference on the Diagnosis of Coronary Heart Disease in People with Diabetes: 10-11 February 1998, Miami, Florida. Diabetes Care 1998;21:1551-9.
8. McGuire DK, Emanuelsson H, Granger CB, Magnus Ohman E, Moliterno DJ, White HD et al. Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO-IIb study. Eur Heart J 2000;21:1750-8.
9. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229-34. (Pubitemid 28350165)
10. Margolis JR, Kannel WS, Feinleib M, Dawber TR, McNamara PM. Clinical features of unrecognized myocardial infarction: silent and asymptomatic: eighteen-year follow-up study: the Framingham study. Am J Cardiol 1973;32:1-7.
11. Nesto RW, Philips RT, Kett KG, Hill T, Perper E, Young E et al. Angina and exertional myocardial ischemia in diabetic and non-diabetic patients: Assessment by exercise thallium scintigraphy. Ann Intern Med 1988;108:170-5. (Pubitemid 18081187)
12. Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 1974;34:29-34.
13. Boudina S, Abel ED. Diabetic cardiomyopathy revisited. Circulation 2007;115:3213-23.
14. Wackers FJ. Diabetes and coronary artery disease: the role of stress myocardial perfusion imaging. Cleve Clin J Med 2005;72:21-5, 29-33.
15. Sabharwal NK, Lahiri A. Role of myocardial perfusion imaging for risk stratification in suspected or known coronary artery disease. Heart 2003;89:1291-7. (Pubitemid 37311087)
16. Freeman M. Myocardial perfusion imaging in diabetes mellitus. Can J Cardiol 2006;22 (Suppl A):22A-25A. (Pubitemid 44963583)
17. Cooper S, Caldwell JH. Coronary artery disease in people with diabetes: diagnostic and risk factor evaluation. Clin Diabetes 1999;17:58-70.
18. Underwood SR, Anagnostopoulos C, Cerqueira M, Ell PJ, Flint EJ, Harbinson M et al. Myocardial perfusion scintigraphy: the evidence. Eur J Nucl Med Mol Imaging 2004;31:261-91.
19. Taillefer R, DePuey EG, Udelson JE, Beller GA, Latour Y, Reeves F. Comparative diagnostic accuracy of Tl-201 and Tc-99m sestamibi SPECT imaging (perfusion and ECG-gated SPECT) in detecting coronary artery disease in women. J Am Coll Cardiol 1997;29:69-77.
20. Kang X, Berman DS, Lewin H, Miranda R, Erel J, Friedman JD et al. Comparative ability of myocardial perfusion single-photon emission computed tomography to detect coronary artery disease in patients with and without diabetes mellitus. Am Heart J 1999;137:949-57.
21. Hachamovitch R, Berman DS, Shaw LJ, Kiat H, Cohen I, Cabico AJ et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation 1998;97:535-43.
22. Beller GA, Zaret BL. Contributions of nuclear cardiology to diagnosis and prognosis of patients with coronary artery disease. Circulation 2000;101:1465-78.
23. Giri S, Shaw LJ, Murthy DR, Travin MI, Miller DD, Hachamovitch R et al. Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation 2002;105:32-40.
24. Wackers FJ, Young LH, Inzucchi SE, Chyun DA, Davey JA, Barrett EJ et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care 2004;27:1954-61.
25. Sharir T, Germano G, Kavanagh PB, Lai S, Cohen I, Lewin HC et al. Incremental prognostic value of post-stress left ventricular ejection fraction and volume by gated myocardial perfusion single photon emission computed tomography. Circulation 1999;100:1035-42.
26. Travin MI, Heller GV, Johnson LL, Katten D, Ahlberg AW, Isasi CR et al. The prognostic value of ECG-gated SPECT imaging in patients undergoing stress Tc-99m sestamibi myocardial perfusion imaging. J Nucl Cardiol 2004;11:253-62.
27. Sharir T, Germano G, Kang X, Lewin HC, Miranda R, Cohen I et al. Prediction of myocardial infarction versus cardiac death by gated myocardial perfusion SPECT: risk stratification by the amount of stress-induced ischemia and the poststress ejection fraction. J Nucl Med 2001;42:831-7.
28. Bell DS. Heart failure: the frequent, forgotten, and often fatal complication of diabetes. Diabetes Care 2003;26:2433-41.
29. Danias PG, Ahlberg AW, Clark BA 3rd, Messineo F, Levine MG, McGill CC et al. Combined assessment of myocardial perfusion and left ventricular function with exercise technetium-99m sestamibi gated single-photon emission computed tomography can differentiate between ischemic and nonischemic dilated cardiomyopathy. Am J Cardiol 1998;82:1253-8.
30. Siebelink HM, Blanksma PK, Crijns HJ, Bax JJ, van Boven AJ, Kingma T et al. No difference in cardiac event free survival between positron emission tomography-guided and single photon emission computed tomography-guided patient management: a prospective, randomized comparison of patients with suspicion of jeopardized myocardium. J Am Coll Cardiol 2001;37:81-8.
31. Rosano GM, Vitale C, Fragasso G. Metabolic therapy for patients with diabetes mellitus and coronary artery disease. Am J Cardiol 2006;98(5A):14J-18J.
32. Knuuti J, Bengel FM. Positron emission tomography and molecular imaging. Heart 2008;94:360-7.
33. Stewart R, Schwaiger M, Molina E, Popma J, Gacioch GM, Kalus M et al. Comparison of rubidium-82 positron emission tomography and thallium-201 SPECT imaging for detection of coronary artery disease. Am J Cardiol 1991;67:1303-10.
34. Tillisch J, Brunken R, Marshall R, Schwaiger M, Mandelkern M, Phelps M et al. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 1986;314:884-8.
35. Hesse B, Tagil K, Cuocolo A, Anagnostopoulos C, Bardiés M, Bax J et al. EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology. Eur J Nucl Med Mol Imaging 2005;32:855-97.
36. Tarakji KG, Brunken R, McCarthy PM, Al-Chekakie MO, Abdel-Latif A, Pothier CE et al. Myocardial viability testing and the effect of early intervention in patients with advanced left ventricular systolic dysfunction. Circulation 2006;113:230-7.
37. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002;39:1151-8.
38. Underwood SR, Bax JJ, vom Dahl J, Henein MY, Knuuti J, van Rossum AC et al. Imaging techniques for the assessment of myocardial hibernation. Report of a Study Group of the European Society of Cardiology. Eur Heart J 2004;25:815-36.
39. Campisi R. Noninvasive assessment of coronary microvascular function in women at risk for ischaemic heart disease. Int J Clin Pract 2008;62:300-7.
40. Di Carli MF, Hachamovitch R. New technology for noninvasive evaluation of coronary artery disease. Circulation 2007;115:1464-80.
41. Nousiainen T, Vanninen E, Jantunen E, Puustinen J, Remes J, Rantala A et al. Comparison of echocardiography and radionuclide ventriculography in the follow-up of left ventricular systolic function in adult lymphoma patients during doxorubicin therapy. J Intern Med 2001;249:297-303.
42. Erbas T, Erbas B, Gedik O, Biberoglu S, Bekdik CF. Scintigraphic evaluation of left ventricular function and correlation with autonomic cardiac neuropathy in diabetic patients. Cardiology 1992;81:14-24.
43. Didangelos TP, Arsos GA, Karamitsos DT, Athyros VG, Karatzas ND. Left ventricular systolic and diastolic function in normotensive type 1 diabetic patients with or without autonomic neuropathy: a radionuclide ventriculography study. Diabetes Care 2003;26:1955-60.
44. Schannwell CM, Schneppenheim M, Perings S, Plehn G, Strauer BE. Left Ventricular Diastolic Dysfunction as an Early Manifestation of Diabetic Cardiomyopathy. Cardiology 2002;98:33-9.
45. Berman DS, Hachamovitch R, Shaw LJ, Friedman JD, Hayes SW, Thomson LE et al. Roles of nuclear cardiology, cardiac computed tomography, and cardiac magnetic resonance: assessment of patients with suspected coronary artery disease. J Nucl Med 2006;47:74-82.
46. Tomas MB, Patel M, Marwin SE, Palestro CJ. The diabetic foot. Br J Radiol 2000;73:443-50.
47. Lipsky BA. Infectious problems of the foot in diabetic patients. Diabet Foot 2001;467-80.
48. Embil JM. The management of diabetic foot osteomyelitis. Diabet Foot 2000;3:76-84.
49. Anderson CA, Roukis TS. The diabetic foot. Surg Clin N Am 2007;87:1149-77.
50. Wrobel JS, Connolly JE. Making the diagnosis of osteomyelitis. The role of prevalence. J Am Podiatr Med Assoc 1998;88:337-43.
51. Giurato L, Uccioli L. The diabetic foot: Charcot joint and osteomyelitis. Nucl Med Commun 2006;27:745-9.
52. Prandini N, Lazzeri E, Rossi B, Erba P, Parisella MG, Signore A. Nuclear medicine imaging of bone infections. Nucl Med Commun 2006;27:633-44.
53. El-Maghraby TA, Moustafa HM, Pauwels EK. Nuclear medicine methods for evaluation of skeletal infection among other diagnostic modalities. Q J Nucl Med Mol Imaging 2006;50:167-92.
54. Palestro CJ, Love C, Tronco GG, Tomas MB, Rini JN. Combined labeled leukocyte and technetium 99m sulfur colloid bone marrow imaging for diagnosing musculoskeletal infection. Radiographics 2006;26:859-70.
55. Palestro CJ, Love C. Nuclear medicine and diabetic foot infections. Semin Nucl Med 2009;39:52-65.
56. Alazraki N, Dries D, Datz F. Value of a 24-hour image (four-phase bone scan) in assessing osteomyelitis in patients with peripheral vascular disease. J Nucl Med 1985;26:711-7.
57. Schauwecker DS. The scintigraphic diagnosis of osteomyelitis. AJR 1992;158:9-18.
58. Filippi L, Schillaci O. Usefulness of hybrid SPECT/CT in 99mTc-HMPAO-labeled leukocyte scintigraphy for bone and joint infections. J Nucl Med 2006;47:1908-13.
59. Horger M, Eschmann SM, Pfannenberg C, Storek D, Dammann F, Vonthein R et al. The value of SPET/CT in chronic osteomyelitis. Eur J Nucl Med Mol Imaging 2003;30:1665-73.
60. Keidar Z, Militianu D, Melamed E, Bar-Shalom R, Israel O. The diabetic foot: initial experience with 18F-FDG-PET/CT. J Nucl Med 2005;46:444-9.
61. Kapoor A, Page S, Lavalley M, Gale DR, Felson DT. Magnetic resonance imaging for diagnosing foot osteomyelitis: a meta-analysis. Arch Intern Med 2007;167:125-32.
62. Syed AA, Rattansingh A, Furtado SD. Current perspectives on the management of gastroparesis. J Postgrad Med 2005;51:54-60.
63. Rajic M, Ilic S, Vlajkovic M, Antic S, Velickovic L, Stefanovic V. Radionuclide staging of renal function in type 1 diabetes mellitus. Ren Fail 2007;29:685-91.
64. Galli G, Rufini V, Vellante C, D'Errico G, Pieraccini R. Estimation of glomerular filtration rate with 99Tc(m)-DTPA: a comparative assessment of simplified methods. Nucl Med Commun1997;18:634-41.
65. Dondi M, Fanti S. Determination of individual renal function through noninvasive methodologies. Curr Opin Nephrol Hypertens1995;4:520-4.
66. Wu HC, Huang WS, Lin CC, Lee CC, Kao A. Objective evidence of a high prevalence of renal damage in women with type 2 diabetes by technetium-99m DMSA renal cortex scan findings. Urology 2003;61:50-4.